211 related articles for article (PubMed ID: 19767084)
61. IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes.
Dickensheets HL; Donnelly RP
J Immunol; 1997 Dec; 159(12):6226-33. PubMed ID: 9550426
[TBL] [Abstract][Full Text] [Related]
62. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
Chen JR; Buchmiller BL; Khan DA
J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
[TBL] [Abstract][Full Text] [Related]
63. Interleukin-4 upregulates RhoA protein via an activation of STAT6 in cultured human bronchial smooth muscle cells.
Chiba Y; Todoroki M; Misawa M
Pharmacol Res; 2010 Feb; 61(2):188-92. PubMed ID: 19857574
[TBL] [Abstract][Full Text] [Related]
64. Cysteinyl leukotriene receptor expression in aspirin-sensitive nasal polyposis patients.
Ozen Z; Mumbuc S; Sari I; Baglam T; Karatas E; Kanlikama M
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):176-80. PubMed ID: 17264534
[TBL] [Abstract][Full Text] [Related]
65. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
Moon Y; Glasgow WC; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
[TBL] [Abstract][Full Text] [Related]
66. CCL23 expression is induced by IL-4 in a STAT6-dependent fashion.
Novak H; Müller A; Harrer N; Günther C; Carballido JM; Woisetschläger M
J Immunol; 2007 Apr; 178(7):4335-41. PubMed ID: 17371990
[TBL] [Abstract][Full Text] [Related]
67. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
Schedel M; Frei R; Bieli C; Cameron L; Adamski J; Lauener R; Kabesch M
J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
[TBL] [Abstract][Full Text] [Related]
68. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.
Liu T; Laidlaw TM; Katz HR; Boyce JA
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16987-92. PubMed ID: 24085850
[TBL] [Abstract][Full Text] [Related]
69. Intranasal ketorolac, diagnosis, and desensitization for aspirin-exacerbated respiratory disease.
Nguyen A; Zuraw BL; Wu C; Kim A; Christiansen SC
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):674-680. PubMed ID: 33476718
[TBL] [Abstract][Full Text] [Related]
70. Pathogenesis of aspirin-exacerbated respiratory disease.
Stevenson DD; Zuraw BL
Clin Rev Allergy Immunol; 2003 Apr; 24(2):169-88. PubMed ID: 12668897
[TBL] [Abstract][Full Text] [Related]
71. Overexpression of IL-9 induced by STAT6 activation promotes the pathogenesis of chronic lymphocytic leukemia.
Chen N; Lu K; Li P; Lv X; Wang X
Int J Clin Exp Pathol; 2014; 7(5):2319-23. PubMed ID: 24966942
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association.
Pham TH; Bak Y; Oh JW; Hong J; Lee S; Hong JT; Yoon DY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010051
[TBL] [Abstract][Full Text] [Related]
73. Upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim JH; Park HS
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
[TBL] [Abstract][Full Text] [Related]
74. Leukotriene receptors and aspirin sensitivity.
Arm JP; Austen KF
N Engl J Med; 2002 Nov; 347(19):1524-6. PubMed ID: 12421897
[No Abstract] [Full Text] [Related]
75. Intranasal ketorolac-induced pancreatitis as a complication of modified oral aspirin desensitization in a patient with aspirin-exacerbated respiratory disease.
Luskin KT; Bosso JV; Simon RA
J Allergy Clin Immunol Pract; 2020 Mar; 8(3):1147-1148. PubMed ID: 31678291
[No Abstract] [Full Text] [Related]
76. Role of expression of prostaglandin synthases 1 and 2 and leukotriene C4 synthase in aspirin-intolerant asthma: a theoretical study.
Dobovišek A; Fajmut A; Brumen M
J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):261-78. PubMed ID: 21331560
[TBL] [Abstract][Full Text] [Related]
77. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
Liu T; Kanaoka Y; Barrett NA; Feng C; Garofalo D; Lai J; Buchheit K; Bhattacharya N; Laidlaw TM; Katz HR; Boyce JA
J Immunol; 2015 Oct; 195(8):3537-45. PubMed ID: 26342029
[TBL] [Abstract][Full Text] [Related]
78. Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease.
Cahill KN
J Allergy Clin Immunol; 2021 Aug; 148(2):344-347. PubMed ID: 34144108
[No Abstract] [Full Text] [Related]
79. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
Steinke JW; Payne SC; Borish L
Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766
[TBL] [Abstract][Full Text] [Related]
80. Aspirin intolerance.
Morassut P; Yang W; Karsh J
Semin Arthritis Rheum; 1989 Aug; 19(1):22-30. PubMed ID: 2505388
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
